VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 187 filers reported holding VAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,078,100 | +2.1% | 845,000 | 0.0% | 3.18% | -2.4% |
| Q2 2023 | $42,199,300 | +51.1% | 845,000 | +13.4% | 3.26% | +77.0% |
| Q1 2023 | $27,922,600 | -19.7% | 745,000 | +2.8% | 1.84% | -15.1% |
| Q4 2022 | $34,763,750 | +75.8% | 725,000 | -12.0% | 2.17% | +130.1% |
| Q3 2022 | $19,769,000 | +10.3% | 823,705 | 0.0% | 0.94% | +6.8% |
| Q2 2022 | $17,924,000 | +117.7% | 823,705 | +97.6% | 0.88% | +159.7% |
| Q1 2021 | $8,235,000 | -25.7% | 416,937 | 0.0% | 0.34% | -28.4% |
| Q4 2020 | $11,078,000 | -65.6% | 416,937 | -36.0% | 0.48% | -70.2% |
| Q3 2020 | $32,159,000 | +15.4% | 651,255 | -26.2% | 1.60% | -11.3% |
| Q2 2020 | $27,877,000 | – | 881,898 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |